Concepts (168)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Heart Transplantation | 9 | 2024 | 862 | 2.290 |
Why?
|
| Heart Failure | 15 | 2024 | 2298 | 1.690 |
Why?
|
| Heart-Assist Devices | 10 | 2024 | 1026 | 1.190 |
Why?
|
| Heart Ventricles | 3 | 2020 | 772 | 0.930 |
Why?
|
| Infant, Premature | 5 | 2019 | 829 | 0.920 |
Why?
|
| Echocardiography | 9 | 2020 | 1056 | 0.810 |
Why?
|
| Transplants | 1 | 2022 | 35 | 0.750 |
Why?
|
| Ventricular Function, Left | 4 | 2022 | 509 | 0.610 |
Why?
|
| Acute Kidney Injury | 2 | 2023 | 637 | 0.590 |
Why?
|
| Heart Defects, Congenital | 3 | 2024 | 1825 | 0.560 |
Why?
|
| Hypertension, Pulmonary | 5 | 2020 | 440 | 0.560 |
Why?
|
| Hypertrophy, Left Ventricular | 1 | 2018 | 109 | 0.550 |
Why?
|
| Thrombosis | 2 | 2022 | 526 | 0.550 |
Why?
|
| Infant, Low Birth Weight | 1 | 2017 | 167 | 0.520 |
Why?
|
| Retrospective Studies | 23 | 2024 | 16353 | 0.510 |
Why?
|
| Kidney Transplantation | 1 | 2021 | 647 | 0.500 |
Why?
|
| Rhabdomyoma | 1 | 2015 | 16 | 0.500 |
Why?
|
| Everolimus | 1 | 2015 | 50 | 0.490 |
Why?
|
| Carotid Arteries | 1 | 2015 | 151 | 0.470 |
Why?
|
| Heart Neoplasms | 1 | 2015 | 101 | 0.460 |
Why?
|
| Pulmonary Artery | 4 | 2019 | 443 | 0.460 |
Why?
|
| Cardiac Catheterization | 3 | 2023 | 634 | 0.450 |
Why?
|
| Catheterization, Peripheral | 1 | 2015 | 125 | 0.440 |
Why?
|
| Kidney Failure, Chronic | 1 | 2021 | 880 | 0.430 |
Why?
|
| Cardiomyopathies | 3 | 2023 | 499 | 0.430 |
Why?
|
| Risk Assessment | 2 | 2019 | 3465 | 0.410 |
Why?
|
| Liver Transplantation | 1 | 2021 | 1037 | 0.400 |
Why?
|
| Infant, Newborn | 12 | 2021 | 8232 | 0.390 |
Why?
|
| Bronchopulmonary Dysplasia | 3 | 2020 | 207 | 0.390 |
Why?
|
| Antineoplastic Agents | 2 | 2022 | 1692 | 0.360 |
Why?
|
| Child | 22 | 2024 | 24418 | 0.350 |
Why?
|
| Pulmonary Circulation | 4 | 2019 | 121 | 0.340 |
Why?
|
| Infant | 15 | 2021 | 12514 | 0.340 |
Why?
|
| Treatment Outcome | 12 | 2024 | 12392 | 0.340 |
Why?
|
| Graft Survival | 2 | 2021 | 538 | 0.310 |
Why?
|
| Male | 21 | 2024 | 61523 | 0.310 |
Why?
|
| Nephrotic Syndrome | 1 | 2009 | 48 | 0.310 |
Why?
|
| Tacrolimus | 1 | 2009 | 98 | 0.300 |
Why?
|
| Female | 22 | 2024 | 66803 | 0.300 |
Why?
|
| Cyclosporine | 1 | 2009 | 147 | 0.300 |
Why?
|
| Drug Resistance | 1 | 2009 | 257 | 0.300 |
Why?
|
| Adolescent | 11 | 2024 | 19362 | 0.290 |
Why?
|
| Humans | 36 | 2024 | 125186 | 0.290 |
Why?
|
| Ventricular Dysfunction, Right | 2 | 2019 | 75 | 0.280 |
Why?
|
| Glomerular Filtration Rate | 2 | 2021 | 507 | 0.280 |
Why?
|
| Ventricular Function, Right | 2 | 2018 | 112 | 0.270 |
Why?
|
| Survival Rate | 3 | 2021 | 2062 | 0.270 |
Why?
|
| Blalock-Taussig Procedure | 2 | 2018 | 51 | 0.270 |
Why?
|
| Blood Flow Velocity | 2 | 2019 | 458 | 0.260 |
Why?
|
| Glucocorticoids | 1 | 2009 | 383 | 0.260 |
Why?
|
| Logistic Models | 2 | 2021 | 1810 | 0.230 |
Why?
|
| Immunosuppressive Agents | 1 | 2009 | 651 | 0.230 |
Why?
|
| Child, Preschool | 9 | 2021 | 14026 | 0.220 |
Why?
|
| Registries | 2 | 2021 | 1435 | 0.220 |
Why?
|
| Cardiomyopathy, Restrictive | 1 | 2023 | 21 | 0.210 |
Why?
|
| Vascular Resistance | 3 | 2019 | 189 | 0.210 |
Why?
|
| Sodium Potassium Chloride Symporter Inhibitors | 2 | 2022 | 32 | 0.210 |
Why?
|
| Prognosis | 4 | 2020 | 4645 | 0.200 |
Why?
|
| Shock, Cardiogenic | 1 | 2024 | 192 | 0.190 |
Why?
|
| Water-Electrolyte Imbalance | 1 | 2022 | 77 | 0.190 |
Why?
|
| Graft Rejection | 2 | 2023 | 590 | 0.180 |
Why?
|
| Heart Failure, Systolic | 1 | 2021 | 34 | 0.180 |
Why?
|
| Heart Valve Diseases | 1 | 2021 | 173 | 0.170 |
Why?
|
| Blood Pressure Determination | 2 | 2019 | 110 | 0.160 |
Why?
|
| Follow-Up Studies | 4 | 2024 | 5176 | 0.160 |
Why?
|
| Risk Factors | 5 | 2024 | 10316 | 0.160 |
Why?
|
| Cohort Studies | 4 | 2021 | 4817 | 0.160 |
Why?
|
| Anemia, Iron-Deficiency | 1 | 2021 | 136 | 0.160 |
Why?
|
| Probability | 1 | 2019 | 320 | 0.160 |
Why?
|
| Bilirubin | 1 | 2019 | 122 | 0.160 |
Why?
|
| Overweight | 1 | 2021 | 364 | 0.150 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2021 | 1056 | 0.150 |
Why?
|
| Heart Diseases | 1 | 2023 | 495 | 0.150 |
Why?
|
| Obesity | 3 | 2021 | 2248 | 0.150 |
Why?
|
| Ventricular Remodeling | 1 | 2019 | 184 | 0.150 |
Why?
|
| Ductus Arteriosus, Patent | 1 | 2020 | 143 | 0.150 |
Why?
|
| Transplant Recipients | 1 | 2019 | 219 | 0.140 |
Why?
|
| Pregnancy in Diabetics | 1 | 2017 | 19 | 0.140 |
Why?
|
| Anticoagulants | 2 | 2022 | 593 | 0.140 |
Why?
|
| Infant, Premature, Diseases | 1 | 2019 | 244 | 0.130 |
Why?
|
| Pulmonary Wedge Pressure | 1 | 2016 | 50 | 0.130 |
Why?
|
| Respiration, Artificial | 1 | 2019 | 473 | 0.130 |
Why?
|
| Nitric Oxide | 1 | 2019 | 493 | 0.130 |
Why?
|
| Kearns-Sayre Syndrome | 1 | 2016 | 6 | 0.130 |
Why?
|
| Cardiac Catheters | 1 | 2015 | 8 | 0.130 |
Why?
|
| Oxygen | 1 | 2019 | 556 | 0.130 |
Why?
|
| Proportional Hazards Models | 1 | 2019 | 1360 | 0.130 |
Why?
|
| Balloon Valvuloplasty | 1 | 2015 | 25 | 0.130 |
Why?
|
| Punctures | 1 | 2015 | 55 | 0.120 |
Why?
|
| Reference Values | 1 | 2017 | 718 | 0.120 |
Why?
|
| Echocardiography, Doppler | 1 | 2016 | 171 | 0.120 |
Why?
|
| Extracorporeal Membrane Oxygenation | 2 | 2019 | 615 | 0.120 |
Why?
|
| Young Adult | 7 | 2024 | 9053 | 0.120 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2023 | 724 | 0.120 |
Why?
|
| Time Factors | 5 | 2024 | 6336 | 0.120 |
Why?
|
| Vascular Patency | 1 | 2015 | 214 | 0.120 |
Why?
|
| Prosthesis Design | 1 | 2018 | 681 | 0.120 |
Why?
|
| Prospective Studies | 4 | 2019 | 6153 | 0.120 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2017 | 228 | 0.120 |
Why?
|
| Renal Dialysis | 1 | 2021 | 855 | 0.120 |
Why?
|
| Angioplasty, Balloon | 1 | 2015 | 172 | 0.110 |
Why?
|
| Cardiomyopathy, Dilated | 1 | 2016 | 213 | 0.110 |
Why?
|
| Multivariate Analysis | 1 | 2018 | 1438 | 0.110 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2017 | 370 | 0.110 |
Why?
|
| Aorta, Thoracic | 1 | 2018 | 533 | 0.110 |
Why?
|
| Lipids | 1 | 2017 | 523 | 0.110 |
Why?
|
| Tooth Discoloration | 1 | 2013 | 1 | 0.110 |
Why?
|
| Postmortem Changes | 1 | 2013 | 11 | 0.110 |
Why?
|
| Gestational Age | 1 | 2017 | 1167 | 0.100 |
Why?
|
| Blood Glucose | 1 | 2017 | 1131 | 0.100 |
Why?
|
| Biopsy | 2 | 2023 | 1238 | 0.100 |
Why?
|
| Predictive Value of Tests | 1 | 2018 | 2174 | 0.100 |
Why?
|
| Severity of Illness Index | 1 | 2020 | 2913 | 0.100 |
Why?
|
| Hemodynamics | 3 | 2022 | 852 | 0.090 |
Why?
|
| Myocardium | 1 | 2016 | 1020 | 0.090 |
Why?
|
| Stroke | 1 | 2018 | 989 | 0.080 |
Why?
|
| Adult | 7 | 2024 | 29627 | 0.080 |
Why?
|
| Stents | 1 | 2015 | 888 | 0.080 |
Why?
|
| Age Factors | 1 | 2015 | 2823 | 0.080 |
Why?
|
| Remission Induction | 1 | 2009 | 300 | 0.070 |
Why?
|
| Acceleration | 2 | 2019 | 26 | 0.070 |
Why?
|
| Hemolysis | 2 | 2021 | 112 | 0.070 |
Why?
|
| Microscopy, Fluorescence | 1 | 2009 | 330 | 0.070 |
Why?
|
| Creatinine | 1 | 2009 | 391 | 0.070 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2017 | 1271 | 0.070 |
Why?
|
| United States | 1 | 2021 | 10914 | 0.060 |
Why?
|
| Postoperative Complications | 1 | 2018 | 3073 | 0.060 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2009 | 1696 | 0.060 |
Why?
|
| Hospitalization | 2 | 2024 | 1783 | 0.060 |
Why?
|
| Chlorides | 1 | 2022 | 107 | 0.050 |
Why?
|
| Hirudins | 1 | 2022 | 37 | 0.050 |
Why?
|
| Antithrombins | 1 | 2022 | 56 | 0.050 |
Why?
|
| Transferrin | 1 | 2021 | 50 | 0.050 |
Why?
|
| Diuretics | 1 | 2022 | 171 | 0.050 |
Why?
|
| Thinness | 1 | 2021 | 70 | 0.050 |
Why?
|
| Sodium | 1 | 2022 | 297 | 0.050 |
Why?
|
| Reproducibility of Results | 2 | 2019 | 2891 | 0.040 |
Why?
|
| American Heart Association | 1 | 2023 | 322 | 0.040 |
Why?
|
| Anti-Arrhythmia Agents | 1 | 2022 | 224 | 0.040 |
Why?
|
| Heparin | 1 | 2022 | 224 | 0.040 |
Why?
|
| Iron | 1 | 2021 | 270 | 0.040 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2022 | 460 | 0.040 |
Why?
|
| Hospital Mortality | 1 | 2024 | 1025 | 0.040 |
Why?
|
| Hemorrhage | 1 | 2022 | 469 | 0.040 |
Why?
|
| Recombinant Proteins | 1 | 2022 | 1399 | 0.040 |
Why?
|
| Biomarkers | 2 | 2018 | 3091 | 0.040 |
Why?
|
| Aortic Valve | 1 | 2021 | 442 | 0.040 |
Why?
|
| Tissue Donors | 1 | 2021 | 494 | 0.040 |
Why?
|
| Peptide Fragments | 1 | 2022 | 780 | 0.040 |
Why?
|
| Anastomosis, Surgical | 1 | 2018 | 171 | 0.040 |
Why?
|
| End Stage Liver Disease | 1 | 2020 | 181 | 0.040 |
Why?
|
| Posterior Leukoencephalopathy Syndrome | 1 | 2018 | 23 | 0.040 |
Why?
|
| Clinical Trials as Topic | 1 | 2021 | 1099 | 0.030 |
Why?
|
| Kidney | 1 | 2023 | 1368 | 0.030 |
Why?
|
| Fetal Blood | 1 | 2017 | 176 | 0.030 |
Why?
|
| Pulmonary Edema | 1 | 2016 | 47 | 0.030 |
Why?
|
| Body Mass Index | 1 | 2021 | 1565 | 0.030 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2016 | 222 | 0.030 |
Why?
|
| Longitudinal Studies | 1 | 2018 | 1324 | 0.030 |
Why?
|
| Forensic Pathology | 1 | 2013 | 8 | 0.030 |
Why?
|
| Phenotype | 1 | 2023 | 4262 | 0.030 |
Why?
|
| Seizures | 1 | 2018 | 872 | 0.020 |
Why?
|
| Hemoglobins | 1 | 2013 | 311 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2016 | 2057 | 0.020 |
Why?
|
| Electrocardiography | 1 | 2016 | 978 | 0.020 |
Why?
|
| Middle Aged | 1 | 2024 | 26928 | 0.010 |
Why?
|
| Pregnancy | 1 | 2017 | 7207 | 0.010 |
Why?
|
| Animals | 1 | 2013 | 34230 | 0.010 |
Why?
|